NYSE:BHC

Bausch Health Companies Stock Insider Trading

Healthcare > Drug Manufacturers - Specialty & Generic

Buy BHC

*Your capital is at risk

$4.95

-0.0600 (-1.20%)

At Close: Jun 03, 2026

Bausch Health Companies Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 99.17. In total, the insiders bought 95.04M and sold 1.99M BHC shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	99.17
● Buy	95.04M shares
● Sell	1.99M shares
77% Buy Activity Weak Negative Correlation
Sell Signal Low Confidence Mar 02, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 99.17. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jul 14, 2025 Buy	Common Shares, No Par Value A-Award	Lee Steven Hyosig SVP, Controller & Cao	Officer	27 371 Value: $173.5K
Jul 14, 2025 Buy	Common Stock J-Other	Lee Steven Hyosig Officer	Officer	0 Value: $0
Jul 14, 2025 Buy	Common Stock J-Other	Lee Steven Hyosig Officer	Officer	0 Value: $0
Jul 14, 2025 Buy	Common Shares, No Par Value A-Award	Lee Steven Hyosig SVP, Controller & Cao	Officer	27 371 Value: $173.5K
Jun 30, 2025 Buy	Common Shares, No Par Value A-Award	Paulson John Director	Director	9 384 Value: $62.5K
Jun 30, 2025 Buy	Common Shares, No Par Value A-Award	Icahn Brett Director	Director	4 034 Value: $26.9K
Jun 30, 2025 Buy	Common Shares, No Par Value A-Award	Wechsler Amy B Director	Director	1 032 Value: $7K
Jun 30, 2025 Buy	Common Shares, No Par Value A-Award	Wechsler Amy B Director	Director	1 032 Value: $7K
Jun 30, 2025 Buy	Common Shares, No Par Value A-Award	Icahn Brett Director	Director	4 034 Value: $26.9K
Jun 30, 2025 Buy	Common Shares, No Par Value A-Award	Paulson John Director	Director	9 384 Value: $62.5K
Jun 13, 2025 Buy	Common Stock, no par value P-Purchase	Paulson John Director	Director	3 564 059 Value: $21.2M
Jun 13, 2025 Buy	Common Stock, no par value P-Purchase	Paulson John Director	Director	3 564 059 Value: $21.2M
Jun 12, 2025 Buy	Common Stock, no par value P-Purchase	Paulson John Director	Director	1 005 376 Value: $5.50M
Jun 12, 2025 Buy	Common Stock, no par value P-Purchase	Paulson John Director	Director	1 005 376 Value: $5.50M
Jun 11, 2025 Buy	Common Stock, no par value P-Purchase	Paulson John Director	Director	1 029 098 Value: $5.39M
Jun 11, 2025 Buy	Common Stock, no par value P-Purchase	Paulson John Director	Director	1 029 098 Value: $5.39M
Jun 10, 2025 Buy	Common Stock, no par value P-Purchase	Paulson John Director	Director	754 134 Value: $3.81M
Jun 10, 2025 Buy	Common Stock, no par value P-Purchase	Paulson John Director	Director	754 134 Value: $3.81M
May 16, 2025 Buy	Common Shares, No Par Value A-Award	Garcia Christian A Director	Director	54 347 Value: $253.8K
May 16, 2025 Buy	Common Shares, No Par Value A-Award	Icahn Brett Director	Director	54 347 Value: $253.8K
May 16, 2025 Buy	Common Shares, No Par Value A-Award	Kavanagh Sarah B Director	Director	54 347 Value: $253.8K
May 16, 2025 Buy	Common Shares, No Par Value A-Award	Lee Frank D. Director	Director	54 347 Value: $253.8K
May 16, 2025 Buy	Common Shares, No Par Value A-Award	Miller Steven D Director	Director	54 347 Value: $253.8K
May 16, 2025 Buy	Common Shares, No Par Value A-Award	Mulligan Richard Director	Director	54 347 Value: $253.8K
May 16, 2025 Buy	Common Shares, No Par Value A-Award	Wechsler Amy B Director	Director	54 347 Value: $253.8K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT BAUSCH HEALTH COMPANIES INC.

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on...

Read Full Profile Here